[1] ROTH GA, MENSAH GA, JOHNSON CO, et al.Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study[J]. Journal of the American College of Cardiology, 2020, 76(25): 2982-3021. [2] The Writing Committee of the Report on Cardiovascular Health Diseases in China. Interpretation of Report on Cardiovascular Health and Diseases in China 2022[J]. Chinese Journal of Cardiovascular Medicine(中国心血管杂志), 2023, 28(4): 297-293. [3] ZHOU M, WANG H, ZENG X, et al.Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: a Systematic Analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. [4] Writing Committee Members, VIRANI SS, NEWBY LK, et al.2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: a Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines[J]. Journal of the American College of Cardiology, 2023, 82(9): 833-955. [5] WANG YG, LIANG F.Guidelines for the Management of Chronic Coronary Heart Disease in the Elderly[J]. Research of Integrated Traditional Chinese and Western Medicine(中西医结合研究), 2023, 15(1): 30-42. [6] MANOLIS AJ, AMBROSIO G, COLLINS P, et al.Impact of Stable Angina on Health Status and Quality of Life Perception of Currently Treated Patients. The BRIDGE 2 Survey[J]. European Journal of Internal Medicine, 2019, 70: 60-67. [7] Chinese College of Cardiovascular Physicians, Doctor Society of Integrative Medicine, Chinese Medical Doctor Association, National Clinical Research Center for Chinese Medicine Cardiology, et al. Chinese Expert Consensus on the Clinical Application of Xinyue Capsules[J]. Journal of Traditional Chinese Medicine(中国中西医结合杂志), 2023, 43(6): 645-652. [8] PAGE MJ, MCKENZIE JE, BOSSUYT PM, et al.The PRISMA 2020 Statement: an Updated Guideline for Reporting Systematic Reviews[J]. The British Medical Journal, 2021, 372: n71. [9] GE JB, XU YJ, WANG C. Internal Medicines(内科学)[M]. ninth edition Beijing: People's Medical Publishing House, 2018: 219, 229-234. [10] WANG J, CHEN G.Expert Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Stable Angina Pectoris of Coronary Heart Disease[J]. Journal of Traditional Chinese Medicine(中医杂志), 2018, 59(5): 447-450. [11] CROCHER TF, LAM N, et al.Risk-of-Bias Assessment Using Cochrane’s Revised Tool for Randomized Trials (RoB 2) Was Useful but Challenging and Resource-Intensive: Observations from a Systematic Review[J]. Journal of Clinical Epidemiology, 2023, 161(2023): 39-45. [12] HIGGINS JPT, THOMAS J, CHANDLER J, et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.5, Cochrane, 2024[EB/OL]. [2025-01-25]. https://training.cochrane.org/handbook. [13] JIA ZM, KANG Y, JIA ZJ.The Treatment Effect of Xinyue Capsule on Stable Angina[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease(中西医结合心脑血管病杂志), 2010, 8(6): 654-655. [14] LIU J.The Efficacy Observation of Xinyue Capsules Combined with Trimetazidine Hydrochloride in the Treatment of Unstable Angina Pectoris[J]. Electronic Journal of Clinical Medical Literature(临床医药文献电子杂志), 2015, 2(13): 2576. [15] ZHANG YJ.Efficacy and Safety Evaluation of Xinyue Capsules in the Treatment of Unstable Angina Pectoris[J]. Health Guide(养生保健指南), 2019(24): 314. [16] ZHAO HL, ZHANG Y, GAO ZC, et al.Clinical Efficacy of Xinyue Capsules in Postmenopausal Women with Stable Angina Pectoris and Self-Reported Insomnia[J]. Journal of Chinese Medicinal Materials(中药材), 2020, 43(9): 2282-2286. [17] ZHANG RX, RU Q, CHEN XA, et al.Clinical Efficacy of Xinyue Capsules Combined with Routine Treatment in Patients with Postmenopausal Unstable Angina Pectoris and Chronic Insomnia[J]. Chinese Traditional Patent Medicine(中成药), 2020, 42(6): 1667-1670. [18] MA L, MA JW, MAO JY.Clinical Study of the Treatment of Elderly Unstable Angina Pectoris with Xinyue Capsules Combined with Trime-tazidine[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebro-vascular Disease(中西医结合心脑血管病杂志), 2020, 18(24): 4185-4188. [19] YAO YJ, YANG MH, HE F, et al.Clinical Study on Xinyue Capsules Combined with Metoprolol in Treatment of Angina Pectoris of Coronary Heart Disease[J]. Drugs & Clinic(现代药物与临床), 2021, 36(12): 2522-2526. [20] WANG HJ, LIU HM, CHI WW, et al.Clinical Efficacy of Combined Use of Panax Quinquefolium Saponin and Western Medicine in Patients with Stable Angina Pectoris and Self-Reported Insomnia in Middle-Aged and Young Adults[J]. Chinese Traditional Patent Medicine(中成药), 2021, 43(5): 1386-1389. [21] SHI BB.The Effect Observation of Xinyue Capsule Combined with Isosorbide Mononitrate in the Treatment of Unstable Angina Pectoris[J]. Journal of Shandong Medical College(山东医学高等专科学校学报), 2022, 44(2): 101-103. [22] LU L.Clinical Analysis of Xinyue Capsule Combined with Tirofiban in the Treatment of Unstable Angina Pectoris[J]. New Mom and New Born(母婴世界), 2022(22): 137-139. [23] DENG YH, LAI T, CHEN GS.Analysis of the Effect of Metoprolol Succinate Tablets Combined with Xinyue Capsules on the Incidence of Angina Pectoris and Myocardial Indicators in Patients with Coronary Heart Disease Angina Pectoris[J]. Modern Diagnosis & Treatment(现代诊断与治疗), 2023, 34(5): 685-687. [24] JIANG Z, QU H, ZHANG Y, et al.Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Interv-ention: a Systematic Review and Meta-Analysis of Randomized Clinical Trials[J]. Evidence-Based Complementary and Alternative Medicine, 2021: 6695868. [25] GE CJ, ZHAO K, TIAN JF, et al.Comprehensive Intervention of Coronary Heart Disease Based on Combining Disease with Syndrome: a Multicenter Randomized Controlled Clinical Study. Chinese Journal of Evidence-Based Cardiovascular Medicine(中国循证心血管医学杂志), 2017, 9(1): 28-32. [26] GUO M, WANG P, DU J, et al.Xinyue Capsule in Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention: a Multicenter, Randomized, Placebo-Controlled Trial[J]. Pharmacological Research, 2020, 158: 104883. [27] CHEN KQ.Clinical Observation of Xinyue Capsule Combined with Deanxit in Treating Anxiety and Depression after PCI for Coronary Heart Disease[D]. Changchun: Changchun University of Chinese Medicine, 2022. [28] WANG YZ, ZHANG JD, XU KL.Effect of Xinyue Capsules Combined with Bisoprolol in Treatment of Angina Pectoris of Coronary Heart Disease and Its Effect on Hemorheology[J]. Drug Evaluation Research(药物评价研究), 2021, 44(5): 1022-1026. [29] WANG PY, YAN KP, ZHANG YY.Clinical Effect of Xinyue Capsules Combined with Felodipine in Treatment of Coronary Heart Disease Angina Pectoris and Its Effect on Serum Cytokines[J]. Drugs & Clinic(现代药物与临床), 2021, 36(5): 926-930. |